BRD7 Antibody

Code CSB-PA865097LA01HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human lung cancer using CSB-PA865097LA01HU at dilution of 1:100

  • Immunofluorescent analysis of MCF-7 cells using CSB-PA865097LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) BRD7 Polyclonal antibody
Uniprot No.
Target Names
BRD7
Alternative Names
75 kDa bromodomain protein antibody; BP75 antibody; BRD 7 antibody; BRD7 antibody; BRD7_HUMAN antibody; Bromodomain containing 7 antibody; bromodomain containing protein 7 antibody; Bromodomain-containing protein 7 antibody; CELTIX 1 antibody; CELTIX1 antibody; NAG4 antibody; Protein CELTIX-1 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Bromodomain-containing protein 7 protein (601-651AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The BRD7 Antibody (Product code: CSB-PA865097LA01HU) is Non-conjugated. For BRD7 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA865097LB01HU BRD7 Antibody, HRP conjugated ELISA
FITC CSB-PA865097LC01HU BRD7 Antibody, FITC conjugated
Biotin CSB-PA865097LD01HU BRD7 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, IHC, IF
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at 'Tyr-216'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR. Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at 'Lys-9' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at 'Lys-382', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase.
Gene References into Functions
  1. the transcriptional signature of low BRD7 expressing cells is associated with increased angiogenesis. PMID: 28951988
  2. our data indicated that BRD7 may serve as a tumor suppressor in hepatocellular carcinoma PMID: 26919247
  3. Results demonstrate a novel function of BRD7 in TGF-beta signaling. BRD7 interacts with the Smad tumor suppressor complex, and enhances both DNA-binding ability and transcriptional activity of Smads. BRD7 functions in growth inhibition and tumor suppression partly as a transcriptional co-activator of Smads. PMID: 27270427
  4. Overexpression of BRD7 inhibited cyclin D and myc expression. Our findings are consistent with a tumor suppressor role for BRD7 in lung adenocarcinoma tumorigenesis. PMID: 27580131
  5. the expression of miR-141 in BRD7-overexpressing NPC cells could partially reverse the tumor suppressive effect of BRD7 on cell proliferation and tumor growth in vitro and in vivo. PMID: 27010857
  6. constructed a regulating network of BRD7 downstream genes, and this network suggests multiple feedback regulations of the pathways. Furthermore, we validated BIRC2, BIRC3, TXN2, and NOTCH1 genes as direct, functional BRD7 targets PMID: 26407966
  7. Propose that the balance between BRD7 function and Ras/Raf/MEK/ERK activity is important for determining the outcomes of HCV infection and HCC development. PMID: 26620707
  8. Ectopic expression of BRD7 could significantly inhibit miR-300-promoted proliferation, invasion and epithelial-mesenchymal transition in osteosarcoma. PMID: 26010572
  9. BRD7 promoter hypermethylation is an indicator of well differentiated oral squamous cell carcinomas. PMID: 25743841
  10. Data indicate that bromodomain-containing protein 7 (BRD7) was a direct target of microRNA-410 (miR-410). PMID: 26149213
  11. lower BRD7 expression is an indicator for poor prognosis in patients with osteosarcoma. PMID: 24840027
  12. These results suggested that BRD7 acts as a tumor suppressor in epithelial ovarian cancers PMID: 24198243
  13. Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4. PMID: 24404152
  14. BRD7-mediated translocation of a subfraction (but not all) of the p85 protein to the nucleus could enhance PI3K signaling. PMID: 24657164
  15. No evidence for breast cancer susceptibility is associated with variants of BRD7. PMID: 22864638
  16. Data show a substantial proportion of germ-line mutations in triple-negative breast cancer (TNBC), with a preponderance of BRCA1 mutations over mutations in BRCA2 or PALB2, but no evidence to implicate BRD7 mutations in the etiology of TNBC. PMID: 23110154
  17. The region from aa219 to aa450 is primarily defined as an atypical nuclear export signal in BRD7. PMID: 21873788
  18. Data indicate that BRD7 may be related to the occurrence, development, and metastasis of lung cancers. PMID: 22008115
  19. miR-200c inhibits the expression of BRD7. MiR-200c regulated the translocation of beta-catenin from the cytoplasm to the nucleus via inhibition of BRD7, resulting in increased expression of its transcriptional target genes, cyclinD1 and c-myc. PMID: 22015043
  20. All-trans retinoic acid enhances brd7 gene expression as HL-60 cells differentiate. PMID: 20561408
  21. as unique regulators of replicative senescence in human cells, both BRD7 and BAF180 regulate p53 transcriptional activity toward a subset of its target genes required for replicative and oncogenic stress senescence induction PMID: 20660729
  22. BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence. PMID: 20228809
  23. Regulation of transcription by E1B-AP5 is mediated by complex formation with this protein. PMID: 12489984
  24. BRD7 could up-regulate the expression levels of BRD2 and BRD3 genes in mRNA level to some extent. PMID: 12600283
  25. Expression levels of NAG-7, and BRD7 did not alter in gastric and colorectal cancers. NAG-7 and BRD7 genes may not play role in gastric and colorectal carcinogenesis. PMID: 12918109
  26. BRD7 inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. PMID: 15137061
  27. Taken together, the present work shed light on the fact that a novel bromodomain gene, BRD7, is of importance in transcriptional regulation and cellular events including cell cycle. PMID: 16265664
  28. the nuclear localization of BRD7 is critical for the expression of cell cycle related molecules and cell biological function. PMID: 16475162
  29. The results showed that BRD7 could interact with BRD2 and the region from amino acid 430 to 798 of BRD2 was critical for the interaction of BRD2 with BRD7. BRD2 mainly localizes in nucleus and BRD2 has distinct roles in initiating apoptosis. PMID: 16786191
  30. BRD7 promoter demethylation is a prerequisite for high level induction of BRD7 gene expression in human nasopharyngeal carcinoma cells PMID: 18778484
  31. BRD7 is a novel PBAF-specific SWI/SNF subunit that is required for target gene activation and repression in embryonic stem cells PMID: 18809673
  32. c-Myc negatively regulates and Sp1 slightly positively regulate BRD7 promoter activity. PMID: 19111069

Show More

Hide All

Subcellular Location
[Isoform 2]: Nucleus.
Database Links

HGNC: 14310

KEGG: hsa:29117

STRING: 9606.ENSP00000378181

UniGene: Hs.437894

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*